Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - journals.lww.com
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …
被引用次数：234 相关文章
[HTML] nih.gov

[HTML][HTML] Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study: Comparison of 106 MEN1/Zollinger-Ellison Syndrome …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - ncbi.nlm.nih.gov
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - hero.epa.gov
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …

T Ito, H Igarashi, H Uehara, MJ Berna… - Medicine, 2013 - pubmed.ncbi.nlm.nih.gov
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

[引用][C] Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - cir.nii.ac.jp
Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: A prospective study: Comparison of 106 men1/zollinger-ellison syndrome patients with …

T Ito, H Igarashi, H Uehara… - Medicine (United …, 2013 - kyushu-u.elsevierpure.com
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: A prospective study: Comparison of 106 men1/zollinger-ellison syndrome patients with …

T Ito, H Igarashi, H Uehara… - Medicine (United …, 2013 - kyushu-u.pure.elsevier.com
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - europepmc.org
Abstract Multiple Endocrine Neoplasia-type 1 (MEN1) is classically characterized by the
development of functional/nonfunctional hyperplasia/tumors in endocrine tissues …
[HTML] nih.gov

[HTML][HTML] Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study. Comparison of 106 MEN1/Zollinger-Ellison Syndrome …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - ncbi.nlm.nih.gov
Abstract Multiple Endocrine Neoplasia-type 1 (MEN1) is classically characterized by the
development of functional/nonfunctional hyperplasia/tumors in endocrine tissues …

Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with …

T Ito, H Igarashi, H Uehara, MJ Berna, RT Jensen - Medicine, 2013 - europepmc.org
Multiple endocrine neoplasia type 1 (MEN1) is classically characterized by the development
of functional or nonfunctional hyperplasia or tumors in endocrine tissues (parathyroid …